Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
Current Opinion in Lipidology|August 12, 2009
Lipoprotein-associated phospholipase A(2) and atherosclerosisRobert L Wilensky, Colin H MacpheeCardiovascular Drugs and Therapy|July 5, 2003
Angiotensin-receptor blockers: revival of the systemic prevention of restenosis?Robert L WilenskyExpert Opinion on Therapeutic Targets|September 12, 2002
Lipoprotein-associated phospholipase A2: a target directed at the atherosclerotic plaqueKeith E Suckling, Colin H MacpheeJournal of the American Heart Association|February 13, 2015
Atherosclerotic plaque inflammation varies between vascular sites and correlates with response to inhibition of lipoprotein-associated phospholipase A2Robert S Fenning, Mark E Burgert, Damir Hamamdzic, et al.Current Opinion in Pharmacology|February 24, 2006
Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic targetColin H Macphee, Jeanenne Nelson, Andrew ZalewskiJournal of Diabetes Research|July 12, 2013
Porcine models of accelerated coronary atherosclerosis: role of diabetes mellitus and hypercholesterolemiaDamir Hamamdzic, Robert L WilenskyDiabetes & Vascular Disease Research|March 17, 2017
Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA2 inhibitor DarapladibNimish K Acharya, Xin Qi, Eric L Goldwaser, et al.Current Opinion in Cardiology|October 9, 2007
The molecular basis of vulnerable plaque: potential therapeutic role for immunomodulationRobert L Wilensky, Damir HamamdzicCurrent Opinion in Lipidology|July 2, 2005
Lipoprotein-associated phospholipase A2 as a target of therapyColin H Macphee, Jeanenne J Nelson, Andrew ZalewskiTopics in Magnetic Resonance Imaging : TMRI|November 21, 2007
Intravascular magnetic resonance imagingVictor A Ferrari, Robert L WilenskyPageof 13